Wednesday, 24 May 2017

Serum Institute of India acquires Czech Republic's Nanotherapeutics

27 April 2017 | News

This acquisition will add to SII group injectable Polio capacity, increasing it by 4 times to a total of 200 million doses by 2019

World's largest vaccine manufacturer Serum Institute of India (SII), has acquired Czech biopharma company Nanotherapeutics for an undisclosed amount. This acquisition will add to SII group injectable Polio capacity, increasing it by 4 times to a total of 200 million doses by 2019, making SII the largest injectable non oral Polio vaccine manufacturer in the world.

Nanotherapeutics has manufacturing capabilities for biologic products that will provide the department of defence and US government with ability to rapidly respond to emerging disease threats and chemical, biologic, radiological and nuclear events.

For SII this is the current acquisition after 2012 in Holland. SII, Pune is currently one of the largest manufacturers of MMR group of vaccines and Pentavalent group of vaccines in the world, present in 147 countries. SII company plans to add around 200 employees in the next 2-3 years in Czech Republic.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

How important is the procurement function in any organisation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls